CompoAtlas

OPTIMA Fémina Ménopause

Food supplement declared in France, declaration No 2019-1-730

OPTIMA Fémina Ménopause (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: retiré du marché le 30 June 2025. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Laboratoires Vitarmonyl
Food business operator placing the product on the market
Laboratoires VITARMONYL
Status
Retiré du marché le 30 June 2025
Form
Capsule
Daily dose
1 capsule JOUR + 1 capsule NUIT
Directions for use
à avaler
Intended populations
Femme
Not recommended for (according to the manufacturer)
Antécédent de cancer du sein
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Peau, Ménopause, Immunité

Declaration 161388, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Citrus sinensis (L.) OsbeckFruitExtrait sec aqueux170 mg
Lithothamnion calcareum (Pallas) AreschougThallePoudre (de plantes séchées ou broyées)150 mg
Borago officinalis L.Graine (huile)Pression à froid135 mg
Humulus lupulus L.CôneExtrait sec hydroalcoolique80 mg

Other active ingredients

NamePer day
Huile de poissonnot declared
Huile de foie de moruenot declared
Phospholipidesnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Béta-carotèneBêta-carotènepas de limite (données insuffisantes)aucune dose fixée
Gluconate ferreuxFer40 mg (niveau de sécurité)14 mg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Levure enrichie en séléniumSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
D-alpha-tocophérolVitamine E300 mg30 mg
Gluconate de zincZinc25 mg15 mg

Additives

E422, E172, E322, E471, E150d

Other ingredients

Gélatine de poisson, huile de soja, Cire d'abeille, huile de tournesol

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Il est recommandé de ne pas consommer en même temps d'autres produits contenant de la vitamine A ou du sélénium.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Borago officinalis L.
    Read the warning, when it applies and the studies cited
  • Humulus lupulus L.
    Read the warning, when it applies and the studies cited

    HOPS - HUMULUS LUPULUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Sleep aid.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists continuously for more than 4 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Other uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Mills and Bone 2005; McGuffin et al. 1997).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid taking with alcohol or products that cause drowsiness (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as this product may cause drowsiness (EMA 2014).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 April 2024

  • Huile de poisson
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

  • Huile de foie de morue
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Laboratoires Vitarmonyl

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line